Travelers Companies (The) (TRV)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
QuarterlyIQ Insights · TRV
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $369 the market pays 2.4× p/b — above the 1.7× p/b peer median but in line with its own 2× history. That premium reflects a durable franchise our peer-anchored $350 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $290–$430. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $340.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $1052.49 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $1060.21 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $92.12 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$290.00 – $430.00 (median $340.00) · 11 analysts · as of 2026-07-21
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $359.05 |
| — |
| — |
| TTM |
| high |
| Peer P/B | 12M | $266.54 | 1.7 | 155.06 | TTM | high |
| Peer P/FCF | 12M | $264.56 | 6.8 | 39.05 | TTM | high |
| Peer P/E | 12M | $517.53 | 14.0 | 36.95 | TTM | high |
| Peer P/S | 12M | $327.52 | 1.4 | 229.30 | TTM | high |
| residual income | 12M | $256.24 | — | — | TTM | high |
| Own P/E history | 12M | $374.99 | 10.1 | 36.95 | TTM | high |
| triangulated | 12M | $580.31 | 14.0 | 41.43 | Triangulated | high |
| Peer P/B | 3Y | $403.93 | 1.7 | 234.99 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $327.55 | 6.8 | 48.35 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $328.71 | 14.0 | 23.47 | Analyst | medium |
| Peer P/S | 3Y | $273.57 | 1.4 | 191.53 | Analyst | medium |
| Own P/E history | 3Y | $238.17 | 10.1 | 23.47 | Analyst | medium |
| Peer P/B | 5Y | $532.94 | 1.7 | 310.04 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $377.67 | 6.8 | 55.74 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $242.88 | 14.0 | 17.34 | Analyst | high |
| Peer P/S | 5Y | $242.64 | 1.4 | 169.87 | Analyst | high |
| Own P/E history | 5Y | $175.98 | 10.1 | 17.34 | Analyst | high |